David Trueman Selected Research

David Trueman Research Topics

3	Heart Failure 12/2018 - 01/2017
2	Neoplasms (Cancer) 11/2022 - 01/2020
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Blindness (Hysterical Blindness) 01/2020
1	Retinal Dystrophies 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 10/2017
1	Inappropriate ADH Syndrome (SIADH) 05/2016
1	Pneumonia (Pneumonitis) 05/2016
1	Weight Gain 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Pain (Aches) 01/2016
1	Schizophrenia (Dementia Praecox) 01/2016
1	Infections 07/2015
1	Cystic Fibrosis (Mucoviscidosis) 07/2015
1	Pseudomonas Infections 07/2015

3	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2018 - 01/2017
2	Enalapril FDA LinkGeneric 12/2018 - 01/2017
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	Vincristine (Oncovin)FDA LinkGeneric 11/2022
1	Brentuximab VedotinIBA 11/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	Tyrosine Kinase InhibitorsIBA 09/2022
1	brigatinibIBA 09/2022
1	Anaplastic Lymphoma KinaseIBA 09/2022
1	lenvatinibIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Vasopressins (Vasopressin)IBA 05/2016
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2016
1	Tolvaptan FDA Link 05/2016
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 05/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	Aripiprazole (Abilify)FDA Link 01/2016
1	Pregabalin (Lyrica)FDA Link 01/2016
1	Lurasidone Hydrochloride FDA Link 01/2016
1	Capsaicin (Zostrix)FDA Link 01/2016
1	Tobramycin (Nebcin)FDA LinkGeneric 07/2015
1	SolutionsIBA 07/2015
1	Lysine (L-Lysine)FDA Link 07/2015
1	Aztreonam FDA LinkGeneric 07/2015

2	Therapeutics 01/2020 - 10/2017
1	Parenteral Nutrition 01/2020
1	Enteral Nutrition (Feeding, Tube) 01/2020